Generali Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.02M Buy
48,043
+27,968
+139% +$1.95M 0.06% 246
2025
Q4
$1.33M Buy
20,075
+1,005
+5% +$65K 0.03% 373
2025
Q3
$1.28M Buy
19,070
+525
+3% +$41.5K 0.03% 376
2025
Q2
$1.62M Buy
18,545
+1,591
+9% +$125K 0.04% 354
2025
Q1
$1.16M Buy
16,954
+1,843
+12% +$150K 0.03% 377
2024
Q4
$1.18M Buy
+15,111
New +$1.12M 0.03% 353

Other funds holding DXCM

Generali Asset Management's DXCM Position: Q1 2026 in Review

Generali Asset Management increased its DexCom (DXCM) stake by 139% in Q1 2026, buying an estimated $1.95M and bringing the position to 48,043 shares worth $3.02M. The position accounts for 0.06% of the portfolio, ranked #246.

Generali Asset Management first reported a position in DXCM in Q4 2024 and has held it in 6 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Generali Asset Management held 48,043 shares of DexCom worth $3.02M as of Q1 2026.
  • Generali Asset Management bought 27,968 DexCom shares in Q1 2026, an estimated $1.95M.
  • DexCom made up 0.06% of Generali Asset Management's portfolio in Q1 2026, its #246 holding.
  • Generali Asset Management first reported a position in DexCom in Q4 2024 and has held it in 6 quarters since.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Generali Asset Management's 13F filing for Q1 2026, filed 5 May 2026.